Citius Oncology (CTOR)

• Market cap: $97.7M
• 1 day: 4.46%
• 5 days: -10%
• 1 month: -31.98%
• 3 months: -38.1%
• 6 months: 31.46%
• Year to date: -1.68%
• 1 year: 37.63%
• 5 years: -88.4%
• 10 years: -88.4%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.